Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Eckert & Ziegler SE's share price for the quarter that ended in Sep. 2024 was €40.4401. Eckert & Ziegler SE's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 20.8 Mil. Therefore, Eckert & Ziegler SE's market cap for the quarter that ended in Sep. 2024 was €843.0 Mil.
Eckert & Ziegler SE's quarterly market cap
increased
from Mar. 2024 (€704.6 Mil) to Jun. 2024 (€862.2 Mil) but then
declined
from Jun. 2024 (€862.2 Mil) to Sep. 2024 (€843.0 Mil).
Eckert & Ziegler SE's annual market cap
declined
from Dec. 2021 (€1,761.5 Mil) to Dec. 2022 (€870.2 Mil) and
declined
from Dec. 2022 (€870.2 Mil) to Dec. 2023 (€775.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Eckert & Ziegler SE's Enterprise Value for Today is €909.4 Mil.
Eckert & Ziegler SE Market Cap Historical Data
The historical data trend for Eckert & Ziegler SE's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eckert & Ziegler SE's Market Cap
For the Medical Devices subindustry, Eckert & Ziegler SE's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eckert & Ziegler SE's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Market Cap distribution charts can be found below:
* The bar in red indicates where Eckert & Ziegler SE's Market Cap falls into.
Eckert & Ziegler SE Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Eckert & Ziegler SE's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eckert & Ziegler SE (XTER:EUZ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Eckert & Ziegler SE Market Cap Related Terms
Thank you for viewing the detailed overview of Eckert & Ziegler SE's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:EUZ has been successfully added to your 